Soyeong Jun
Overview
Explore the profile of Soyeong Jun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jun S, Shukla N, Hanna N, Diehn M
J Thorac Oncol
. 2024 Dec;
19(12):e93-e94.
PMID: 39645313
No abstract available.
2.
Jun S, Shukla N, Durm G, Hui A, Cao S, Ganti A, et al.
J Thorac Oncol
. 2024 Jul;
19(10):1427-1437.
PMID: 38971369
Introduction: The current standard of care for patients with inoperable stage III non-small cell lung cancer includes chemoradiotherapy (CRT) followed by 1 year of checkpoint inhibitor (CPI) therapy. Nevertheless, the...
3.
Mathew D, Marmarelis M, Foley C, Bauml J, Ye D, Ghinnagow R, et al.
Science
. 2024 Jun;
384(6702):eadf1329.
PMID: 38900877
Persistent inflammation driven by cytokines such as type-one interferon (IFN-I) can cause immunosuppression. We show that administration of the Janus kinase 1 (JAK1) inhibitor itacitinib after anti-PD-1 (programmed cell death...
4.
Kim T, Lim H, Jun S, Park J, Lee D, Lee J, et al.
Sci Rep
. 2023 Nov;
13(1):20485.
PMID: 37993659
Gynecologic cancer, including ovarian cancer and endometrial cancer, is characterized by morphological and molecular heterogeneity. Germline and somatic testing are available for patients to screen for pathogenic variants in genes...
5.
Hyun J, Jun S, Lim H, Cho H, You S, Ha S, et al.
ACS Synth Biol
. 2021 Sep;
10(10):2478-2487.
PMID: 34525796
Neoantigen vaccines are an immunotherapy strategy for treating cancer. The vaccine degrades quickly, so the strategy must include protection and precise targeting for immune cell stimulation. In this study, we...
6.
Lim H, Jun S, Park M, Lim J, Jeong J, Lee J, et al.
ACS Synth Biol
. 2020 Apr;
9(5):1003-1009.
PMID: 32348672
We developed a clustered regularly interspaced short palindromic repeats (CRISPR)/retron system for multiplexed generation of substitution mutations by coutilization of a retron system that continuously expresses donor DNA and a...
7.
Jun S, Lim H, Chun H, Lee J, Bang D
Commun Biol
. 2020 Apr;
3(1):154.
PMID: 32242071
CRISPR-based screening methods using single-cell RNA sequencing (scRNA-seq) technology enable comprehensive profiling of gene perturbations from knock-out mutations. However, evaluating substitution mutations using scRNA-seq is currently limited. We combined CRISPR...
8.
Lee W, Lee J, Jun S, Lee J, Bang D
Sci Rep
. 2018 Aug;
8(1):11879.
PMID: 30089886
Mutations within the KRAS oncogene are associated with the proliferation of various cancers. Therapeutic approaches for treating cancers with such mutations have focused on targeting the downstream protein effectors of...
9.
Jun S, Lim H, Jang H, Lee W, Ahn J, Lee J, et al.
ACS Synth Biol
. 2018 Jun;
7(7):1651-1659.
PMID: 29924933
CRISPR/Cas9 for genome editing requires delivery of a guide RNA sequence and donor DNA for targeted homologous recombination. Typically, single-stranded oligodeoxynucleotide, serving as the donor template, and a plasmid encoding...